This book elaborates on current practices and policies relating to the research, development, dissemination and application of therapies aimed at improving degenerative ageing processes and extending healthy, productive longevity. It explores the intersection of longevity science, technology and society, and addresses issues such as R&D and educational policies, governance, regulation and the accessibility of emerging therapies.
It examines the practical implementation of policies for longevity therapy research, including the factors that hinder or encourage beneficial development. Key topics include the definition and evaluation of clinical benefits, regulatory frameworks and methodological issues in geroscience research. The book also considers the practical benefits of longevity studies and emerging therapies, with a focus on safety, efficacy, standardisation, and universal distribution.
Written by world-leading experts, this book makes a valuable contribution to the analysis of methodological and policy challenges, and the devising of biomedical and societal solutions to improve healthy longevity for the population.
Good Practices in Healthy Longevity Medicine.- A New Medical Specialty:
Clinical Guidelines and Standards for Practice and Physician Training in
Healthspan Optimization.- Integrating Preventive Healthcare for Lifelong
Well-being: Policy Strategies and Practical Approaches.- The Role of
Longevity Medicine in Reforming Primary Healthcare.- Technological
Innovations in Aging: Policy Responses and Best Practices for Healthy
Longevity.- Pre-adult Healthspan Interventions (PHI): Enhancing Fulfilment
and Longevity.- What is Aging and Healthy Longevity?.- The Evolving Lexicon
of Longevity.- AgingasMeta-Disease: A Comprehensive Framework Integrating
Set Theory with Cellular Senescence as Causal Nexus.- Wicked Issues in
Healthy Longevity.- The Right to Health and Longevity An Evolving Human
Right.- Enhancing Longevity Research, Development, Education and Application
through Public Health and Research Policy.- Applied Bioethics in Current
Longevity Medicine Policy and Practice.- A Political and Financial Blueprint
for Longevity Industrialization.- Healthy Longevity: A Longer Living
Society.- Longevity of Longevity Data.- Big Health Data Analyzed with AI for
Longevity: How Public Institutions Could and Should Use It.- New Frontier of
Longevity Through the Framework of the Exposome.- Longevity Real Estate:
Scaling AI for Longevity to Integrated Residential, Commercial, and Clinical
Research Communities.- Analysis of Healthy Longevity in Africa: Policies,
Challenges, and Opportunities.- Jewish Policies and Practices for Healthy
Longevity.- Good Practices from Longevity Activism in Slovenia.- Transforming
Institutions from Sickcare to Longevity.- The Road Not Taken: Lessons from
British Ageing Research Policies and Initiatives.
Ilia Stambler, PhD, is the Chief Science Officer and Chairman of Vetek (Seniority) Association the Movement for Longevity and Quality of Life, Israel, and Chairman of International Longevity Alliance (ILA). He is a fellow at the Department of Science, Technology and Society, Bar Ilan University, Israel. His research focuses on the historical and social implications of aging and longevity research, including ethical, policy, and regulatory aspects. Dr. Stambler is actively involved in advocacy for aging and longevity research and holds leadership roles in multiple organizations for healthy longevity research and advocacy. He has authored several books and over 80 academic papers.
